| ‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA |
| Adverse effects of COVID-19 vaccines and measures to prevent them |
| Alternate mechanisms of mRNA vaccine toxicity: which one is the main culprit? |
| Anti-recoverin Antibody-Associated Post-acute COVID Vaccination Syndrome After BNT162b2 in HLA-B27-Positive Spondylarthritis: A Case Report |
| Commentary from Dr. David Bauer of the Francis Crick Institute |
| COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 1 |
| COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2 |
| COVID-19 vaccines – An Australian Review |
| Extended SARS-CoV-2 RBD booster vaccination induces humoral and cellular immune tolerance in mice |
| Homology between SARS CoV-2 and human proteins |
| Hybrid and herd immunity 6 months after SARS-CoV-2 exposure among individuals from a community treatment program |
| Innate Immune Suppression by SARS-CoV-2 mRNA Vaccinations: The role of G-quadruplexes, exosomes and microRNAs |
| mRNA Vaccine Toxicity |
| SARS-CoV-2 Spike protein suppresses CTL-mediated killing by inhibiting immune synapse assembly |
| Strategies for the Management of Spike Protein-Related Pathology |
| Transmission of SARS-CoV-2 Delta Variant Among Vaccinated Healthcare Workers, Vietnam |
| Urgent Open Letter from Doctors and Scientists to the European Medicines Agency regarding COVID-19 Vaccine Safety Concerns |
| Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation |
